Profile
David C.
Rees worked as Director & Head-Medicinal Chemistry at AstraZeneca PLC, Principal at Harvard University, N.V.
Organon, and Parke-Davis & Co. Ltd., Vice President-Medicinal Chemistry at Astex Therapeutics Ltd. from 2003 to 2009, and Senior Vice President-Medicinal Chemistry at Astex Pharmaceuticals, Inc.
Former positions of David C. Rees
| Companies | Position | End |
|---|---|---|
Astex Pharmaceuticals, Inc.
Astex Pharmaceuticals, Inc. BiotechnologyHealth Technology Researches and develops drugs for oncology & CNS disorders | Corporate Officer/Principal | - |
Organon NV
Organon NV Pharmaceuticals: MajorHealth Technology Develops manufactures and sells prescription medicines | Corporate Officer/Principal | - |
| ASTRAZENECA PLC | Director/Board Member | - |
Parke-Davis & Co. Ltd.
Parke-Davis & Co. Ltd. Pharmaceuticals: MajorHealth Technology Operates pharmaceutical company | Corporate Officer/Principal | - |
Harvard University
Harvard University Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | - |
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Private companies | 6 |
|---|---|
AstraZeneca PLC
AstraZeneca PLC Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
Harvard University
Harvard University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Organon NV
Organon NV Pharmaceuticals: MajorHealth Technology Develops manufactures and sells prescription medicines | Health Technology |
Parke-Davis & Co. Ltd.
Parke-Davis & Co. Ltd. Pharmaceuticals: MajorHealth Technology Operates pharmaceutical company | Health Technology |
Astex Therapeutics Ltd.
Astex Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Discovers and develops fragment based drug | Health Technology |
Astex Pharmaceuticals, Inc.
Astex Pharmaceuticals, Inc. BiotechnologyHealth Technology Researches and develops drugs for oncology & CNS disorders | Health Technology |
- Stock Market
- Insiders
- David C. Rees
















